drugset / Trial / NCT06007417
A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of weekly GenSci004 compared with daily Genotropin in treatment-naive children with growth failure due to GHD.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2025-05-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci004 | Protein / enzyme biologic | — | — |
| Comparator | Somatropin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.